A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Small Cell Lung Cancer
Both
Small Cell Lung Cancer
Trial Information
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell
Inclusion Criteria:
- Age ≥ 18
- Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results
- Scheduled to undergo first-, second- or third-line treatment for SCLC, including
chemotherapy, chemotherapy + radiation therapy, or combined concurrent
chemoradiotherapy.
- Able to understand and willing to provide Informed Consent
Exclusion Criteria:
- No diagnosis of SCLC
- Not scheduled to undergo treatment for the diagnosis of SCLC
- Unable to provide Informed Consent
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Authority:
United States: Institutional Review Board
Study ID:
FDI-36
NCT ID:
NCT01591512
Start Date:
May 2011
Completion Date:
April 2014
Related Keywords:
- Small Cell Lung Cancer
- Small Cell Lung Cancer
- SCLC
- Lung Cancer
- Subjects diagnosed with SCLC who will undergo treatment
- Lung Neoplasms
- Small Cell Lung Carcinoma
Name | Location |
|---|---|
| Heartland Regional Medical Center | Saint Joseph, Missouri 64506 |
| Hematology Oncology Consultants, Inc. | St. Louis, Missouri 63136 |
| Kelly Family Medical Center, PC | Eastpointe, Michigan 48021 |
| St.Louis Cancer Care, LLP | Bridgeton, Missouri 63044 |
